A systemic study of enhancement of host defense processes against bacterial infection.
A sequence of studies over more than two decades has identified a variety of host defense abnormalities that may contribute to clinical infection in high risk and/or badly injured patients. Clearly, animal studies set the stage for our clinical applications and suggest that a variety of so-called non-specific host defense stimulants may indeed correct many of these abnormalities and promote the ultimate control of surgical infections.
Polk
H C
HC
Department of Surgery, University of Louisville School of Medicine, Kentucky 40292.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D013530:Surgical Wound Infection / Q000276:immunology* / Q000517:prevention & control
D000276:Adjuvants, Immunologic